Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Indiana Healthcare Today.
Press releases published on September 2, 2025
Coag-Sense® PT/INR Monitoring System Approved for Patient Self-Testing in Europe
GlobeNewswire
·
September 2, 2025
FREMONT, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- CoaguSense, Inc., a subsidiary of i-SENS (KOSDAQ:099190), today announced that it has received approval for the sale of the Coag-Sense® PT/INR Monitoring System for patient self-testing in Europe. The …
Step Pharma announces first participant dosed in a phase 1b clinical trial of dencatistat for essential thrombocythaemia
GlobeNewswire
·
September 2, 2025
Start of the phase 1b trial in a new indication expands Step Pharma’s clinical programme, building on the development of dencatistat in lymphoma and solid tumours This milestone marks the third indication for dencatistat, a first-in-class, highly selective …
Lisata Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
BASKING RIDGE, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …
Clene to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
SALT LAKE CITY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the …
Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
WATERTOWN, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to …
Erasca to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
September 2, 2025
SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today …
PDS Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
PRINCETON, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
NORCROSS, Ga., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that the company management will participate in the H.C. Wainwright 27th …
Highridge Medical Acquires Innovative Products from Accelus to Expand Capabilities in Spine Surgery
GlobeNewswire
·
September 2, 2025
WESTMINSTER, Colo., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Highridge Medical, one of the world’s largest privately held spine companies with an innovative portfolio supported by extensive clinical evidence, announced today its acquisition of the FlareHawk® and …
Department of Defense (DoD) Awards Nearly $1 Million to Steadman Philippon Research Institute (SPRI) for Breakthrough Study on Extracellular Vesicles Therapeutic for Joint Regeneration
GlobeNewswire
·
September 2, 2025
VAIL, Colorado / BASALT, Colorado, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The U.S. Department of Defense (DoD) has awarded a $962,977 contract to Steadman Philippon Research Institute (SPRI) to launch a year-long clinical study focused on improving therapies …
REMINDER – Biocodex Microbiota Foundation invites Canadian academics and scientists to apply for €35,000 research grant
GlobeNewswire
·
September 2, 2025
MONTREAL, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Biocodex Microbiota Foundation, an organization founded by Biocodex and dedicated to inspiring scientific projects that explore the microbiome, is calling for grant proposals from innovative researchers at …
RAPPEL – La Fondation du Microbiote de Biocodex invite les universitaires et scientifiques canadiens à soumettre leur candidature pour une bourse de recherche de 35 000 €
GlobeNewswire
·
September 2, 2025
MONTRÉAL, 02 sept. 2025 (GLOBE NEWSWIRE) -- La Fondation du Microbiote de Biocodex, une organisation fondée par Biocodex et ayant pour vocation d’inspirer des projets scientifiques explorant le microbiote, lance un appel à projets de subvention aux …
PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH NUPSALA LIMITED
GlobeNewswire
·
September 2, 2025
MINNEAPOLIS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- PetVivo Animal Health, Inc., a wholly-owned subsidiary of PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) (collectively referred to herein as "PetVivo"), is an emerging biomedical device company focused on …
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director
GlobeNewswire
·
September 2, 2025
ARLINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, …
Vielight Neuro Technology Gains Traction Across Professional Sports, Powering Champions with Evidence-Backed Results
GlobeNewswire
·
September 2, 2025
Toronto, Ontario, Sept. 02, 2025 (GLOBE NEWSWIRE) -- TORONTO — Aug. 28, 2025 — Vielight, the pioneers of brain photobiomodulation (PBM) neurotechnology, is rapidly emerging as a game-changer for elite athletes. NFL and NCAA football players, Olympic …
IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires, Joe Kiani Appointed as New Director
GlobeNewswire
·
September 2, 2025
ORLANDO, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed” or the “Company”) (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging (“MRI”)-compatible patient monitoring and infusion systems, today …
Nasus Pharma Announces Upcoming Presentation at H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
TEL AVIV, Israel, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical …
Vor Bio Appoints Adi Osovsky, S.J.D. as General Counsel
GlobeNewswire
·
September 2, 2025
CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Adi Osovsky, S.J.D. as General Counsel. Dr. Osovsky …
Hopebridge Continues to Grow Autism Therapy Services in Founding State of Indiana
GlobeNewswire
·
September 2, 2025
Indianapolis, Sept. 02, 2025 (GLOBE NEWSWIRE) -- As autism spectrum disorder (ASD) diagnoses continue to rise, the demand for early identification and therapeutic intervention is greater than ever. Hopebridge Autism Therapy Centers, one of the nation’s …
Opus Genetics Appoints Rob Gagnon as Chief Financial Officer
GlobeNewswire
·
September 2, 2025
RESEARCH TRIANGLE PARK, N.C., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic …